Citadel Advisors Portfolio holdings
Citadel Advisors, founded in 1990 by Kenneth C. Griffin as Citadel LLC and headquartered in Chicago, Illinois, is one of the world’s most prominent hedge funds, managing tens of billions in assets through sophisticated quantitative trading strategies. The firm excels in market-making and high-frequency trading across asset classes like equities, fixed income, options, and commodities, leveraging cutting-edge technology and data analysis to generate returns. Citadel operates two main arms: its hedge fund business, which serves institutional and high-net-worth investors, and Citadel Securities, a leading market maker that facilitates a significant portion of U.S. equity and options trades. Known for its secretive, high-performance culture, Citadel has grown into a financial titan under Griffin’s leadership, influencing global markets with its scale and innovation.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$555M |
| 2 |
Citigroup
C
|
+$407M |
| 3 |
Medtronic
MDT
|
+$401M |
| 4 |
Chipotle Mexican Grill
CMG
|
+$392M |
| 5 |
Gilead Sciences
GILD
|
+$362M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$1.43B |
| 2 |
Amazon
AMZN
|
+$1.32B |
| 3 |
Apple
AAPL
|
+$1.1B |
| 4 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$995M |
| 5 |
Bank of America
BAC
|
+$726M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 83.47% |
| 2 | Technology | 3.02% |
| 3 | Healthcare | 2.92% |
| 4 | Consumer Discretionary | 2.17% |
| 5 | Financials | 2.1% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ALLK
13901
PUT
DELISTED
Allakos
ALLK
| $653 | ﹤0.01% |
1,000
-400
| -29% | -$290 |
2019 Q3
20 quarters
|
|
|
VMCAW
13902
DELISTED
Valuence Merger Corp. I Warrant
VMCAW
| $652 | ﹤0.01% |
20,064
-20,720
| -51% | -$700 |
2023 Q1
6 quarters
|
|
|
ROCLW
13903
DELISTED
Roth CH Acquisition V Co. Warrant
ROCLW
| $650 | ﹤0.01% |
13,764
-1,850
| -12% | -$102 |
2023 Q1
6 quarters
|
|
13904
Cellectar Biosciences
CLRB
$16.6M
| $648 | ﹤0.01% |
10
-1,664
| -99% | -$110K |
2023 Q4
3 quarters
|
|
|
NVNIW
13905
Nvni Group Limited Warrants
NVNIW
$315K
| $635 | ﹤0.01% |
30,809
+19,268
| +167% | +$620 |
2023 Q4
3 quarters
|
|
|
AREBW
13906
DELISTED
American Rebel Holdings Warrants
AREBW
| $629 | ﹤0.01% |
622
-18
| -3% | -$24 |
2023 Q4
3 quarters
|
|
|
PDYNW
13907
DELISTED
Palladyne AI Corp Warrants
PDYNW
| $627 | ﹤0.01% |
20,914
| – | – |
2024 Q1
2 quarters
|
|
13908
PUT
Ocean Power Technologies
OPTT
$8.94M
| $623 | ﹤0.01% |
+133
| New | +$985 |
2024 Q3
0 quarters
|
|
13909
CALL
Entravision Communication
EVC
$687M
| $621 | ﹤0.01% |
+300
| New | +$599 |
2024 Q3
0 quarters
|
|
13910
PUT
Prelude Therapeutics
PRLD
$289M
| $621 | ﹤0.01% |
300
+200
| +200% | +$926 |
2024 Q2
1 quarter
|
|
|
MTA
13911
CALL
Metalla Royalty & Streaming
MTA
$856M
| $618 | ﹤0.01% |
+200
| New | +$588 |
2024 Q3
0 quarters
|
|
|
WW
13912
DELISTED
WW International
WW
| $617 | ﹤0.01% |
703
| – | – |
2023 Q3
4 quarters
|
|
|
SVMHW
13913
DELISTED
SRIVARU Holding Limited Warrant
SVMHW
| $596 | ﹤0.01% |
39,750
-1,301
| -3% | -$14 |
2023 Q4
3 quarters
|
|
13914
PUT
Celularity
CELU
$54.5M
| $594 | ﹤0.01% |
200
-1,400
| -88% | -$4.13K |
2024 Q1
2 quarters
|
|
13915
CALL
Holley
HLLY
$281M
| $590 | ﹤0.01% |
200
-3,800
| -95% | -$12.7K |
2021 Q3
12 quarters
|
|
13916
PUT
Ovid Therapeutics
OVID
$455M
| $590 | ﹤0.01% |
500
+300
| +150% | +$313 |
2024 Q1
2 quarters
|
|
|
OCEA
13917
PUT
DELISTED
Ocean Biomedical, Inc. Common Stock
OCEA
| $588 | ﹤0.01% |
600
+400
| +200% | +$428 |
2024 Q1
2 quarters
|
|
|
SLXNW
13918
Silexion Therapeutics Warrant
SLXNW
$31.4K
| $583 | ﹤0.01% |
+18,405
| New | +$1.07K |
2024 Q3
0 quarters
|
|
13919
CALL
US Gold Corp
USAU
$237M
| $581 | ﹤0.01% |
100
-800
| -89% | -$4.48K |
2024 Q2
1 quarter
|
|
13920
PUT
Concrete Pumping Holdings
BBCP
$498M
| $579 | ﹤0.01% |
+100
| New | +$611 |
2024 Q3
0 quarters
|
|
13921
PUT
Orion Group Holdings
ORN
$376M
| $577 | ﹤0.01% |
100
-3,200
| -97% | -$24.6K |
2022 Q4
7 quarters
|
|
|
SIFY
13922
PUT
Sify Technologies
SIFY
$951M
| $576 | ﹤0.01% |
+267
| New | +$649 |
2024 Q3
0 quarters
|
|
13923
CALL
Urban One Class D
UONEK
$16.4M
| $555 | ﹤0.01% |
+50
| New | +$664 |
2024 Q3
0 quarters
|
|
|
TSVT
13924
DELISTED
2seventy bio
TSVT
| $552 | ﹤0.01% |
117
-18,887
| -99% | -$85.2K |
2022 Q2
9 quarters
|
|
13925
CALL
ProQR Therapeutics
PRQR
$230M
| $546 | ﹤0.01% |
300
-1,500
| -83% | -$2.82K |
2023 Q4
3 quarters
|
|
Similar funds
Citadel Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, Citadel Advisors held 15,731 positions worth $518B, up 4.9% from $494B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Citadel Advisors's Q3 2024 filing shows 1,612 new, 6,434 increased, 5,866 reduced and 1,610 closed positions. Its largest new stake was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M. The largest sale was Invesco QQQ Trust, an estimated $1.43B.
By sector, the portfolio is most concentrated in Miscellaneous at 83% of assets, up from 82% a quarter earlier, followed by Technology and Healthcare.
- Citadel Advisors's largest Q3 2024 buy was iShares 7-10 Year Treasury Bond ETF: 2,002,737 shares worth $197M.
- Citadel Advisors added most to NVIDIA in Q3 2024, an estimated $555M increase.
- Citadel Advisors's biggest Q3 2024 reduction was Invesco QQQ Trust, cutting an estimated $1.43B.
- Citadel Advisors fully exited Domino's in Q3 2024, selling an estimated $186M.
- Citadel Advisors's ten largest holdings make up 30% of its $518B portfolio in Q3 2024.
- Citadel Advisors opened 1,612 new positions and closed 1,610 in Q3 2024.
- Citadel Advisors's portfolio value rose 4.9% quarter-over-quarter to $518B.
Based on Citadel Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.